Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung Cancer
Comparison of Two Techniques of Video Assisted Thoracic Surgery (VATS) Uniportal Lobectomies Through the Transcervical and Standard Intercostal Approaches for Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) in the Prospective Randomized Single-institutional Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Introduction Video-assisted thoracoscopic surgery (VATS) pulmonary lobectomy became an accepted method for the treatment of early-stage Non-Small-Cell Lung Cancer (NSCLC). There are several variants of VATS lobectomy. In recent years the uniportal approach described by Gonzales-Rivas gained a world-wide interest. The uniportal VATS approach can be performed through the intercostal incision as has been practiced in vast majority of published cases, but there is also another approach, namely the transcervical one, first described by Zakopane team in 2007. In that time, right upper lobectomy and afterwards the left upper lobectomy through the transcervical approach combined with single-port intercostal VATS were performed. The method was to combine lobectomy with Transcervical Extended Mediastinal Lymphadenectomy (TEMLA), preceding a pulmonary resection with intraoperative examination of the mediastinal nodes with the imprint cytology technique. From 2016, after adopting the technique of uniportal intercostal lobectomy, transcervical VATS uniportal lobectomies, without additional intercostal ports were performed. Now, resection of any rightsided or left-sided lobe with the transcervical approach are feasible to be performed.
Surgical Technique Preparation The patient is positioned supine on the operating table with a roll placed beneath the thoracic spine to elevate the chest and to hyperextend the patient's neck. Under general anaesthesia an endobronchial tube is inserted to conduct selective lung ventilation during the latter part of the procedure.
A transverse 6-8 cm transcervical collar incision is made in the neck in a standard way with division and suture-ligation of the anterior jugular veins bilaterally. The sternal manubrium is elevated with sharp one-tooth hook connected to the Zakopane II frame (Aesculap-Chifa, BBraun, Nowy Tomysl, Poland) to widen the access to the mediastinum. The first part of the procedure is TEMLA. The technique of this procedure, and possible pitfalls and the methods of management of intraoperative complications were published elsewhere [6]. In brief, the technique of TEMLA included dissection of all mediastinal nodal stations except for the pulmonary ligaments nodes (station 9). The subcarinal nodes, the periesophageal nodes, the right and left lower paratracheal nodes, and the right hilar nodes (stations 7, 8, 4R, 4L and 10R) were removed in the mediastinoscopy-assisted technique and the paraaortic and the pulmonary-window nodes (stations 6 and 5) are removed in the videothoracoscopy-assisted technique, with the videothoracoscope inserted through the transcervical incision. The superior mediastnal nodes and upper right and left paratracheal nodes (stations 1, 2R and 2L) are removed in the open surgery fashion under direct eye control. The prevascular and retrotracheal nodes (stations 3A and 3P) are removed in pre-selective cases. Generally, the mediastinal pleura is not violated and no drain is left in the mediastinum. Bilateral supraclavicular lymphadenectomy and even deep cervical lymph node dissection is possible during TEMLA through the same incision.
The nodes removed during TEMLA are sent sequentially to intraoperative pathologic examination with use of the imprint cytology technique [4]. The imprint cytology technique is a highly reliable technique much less time consuming than a frozen section analysis. Due to this advantage the time of nodal examinations adds only 15 to 20 minutes to the total time of the operation. After receiving the negative results of the imprint cytology, confirming there are no nodal metastasis the VATS lobectomy part starts. The position of the patient is slightly changed with the introduction of the roll beneath the patient's operating side. Additionally, the operating table is rotated to achieve a semi-lateral position of the patient. The ventillation of the operated lung is disconnected and the mediastinal pleura is opened. Further dissection is performed with the use of endostaplers to manage the lobar vesselts, bronchus and interlobar fissures.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Marcin Zielinski, MD PhD
- Phone Number: 179 0048182015045
- Email: marcinz@mp.pl
Study Contact Backup
- Name: Marcin Zielinski
- Phone Number: 0048182015045 0048182015045
- Email: marcinz@mp.pl
Study Locations
-
-
-
Zakopane, Poland, 34-500
- Recruiting
- Pulmonary Hospital
-
Contact:
- Marcin Zielinski, MD Phd
- Phone Number: 179 +48182015045
- Email: marcinz@mp.pl
-
Contact:
- Marcin Zielinski, MD Phd
- Phone Number: 0048182015045 0048182015045
- Email: marcinz@mp.pl
-
Principal Investigator:
- Michal Wilkojc
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with histologically, or cytologically proven clinical stage I (cI) NSCLC
Exclusion Criteria:
- Patients with more advanced NSCLC than clinical stage I (cI) NSCLC
- Severe atherosclerotic lesions of the innominate artery and the aortic arch and previous cardiac surgery.
- Severe pleural adhesions and calcified intrapulmonary nodes after previous tuberculosis are also technical obstacles for this kind of surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: uniportal transcervical approache
Uniportal lobectomy with complete lymphadenectomy - transcervical approach with elevation of the sternum
|
uniportal lobectomy with complete lymphadenectomy
|
|
Experimental: uniportal intercostal approache
Uniportal lobectomy with complete lymphadenectomy - intercostal approache
|
uniportal lobectomy with complete lymphadenectomy
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
time of the procedure
Time Frame: 4 weeks
|
duration of the operation in minutes
|
4 weeks
|
|
number of conversions to multi-portal VATS and/or open thoracotomy
Time Frame: 4 weeks
|
number of conversions to multi-portal VATS and/or open thoracotomy
|
4 weeks
|
|
duration of chest drainage
Time Frame: 4 weeks
|
duration of chest drainage in days
|
4 weeks
|
|
volume of chest drainage
Time Frame: 4 weeks
|
volume of chest drainage in ml
|
4 weeks
|
|
amount of postoperatve pain
Time Frame: up to 72 hours after the end of surgery
|
1.pain intensity 0-100 mm VAS scale measured every 4 hours on standard ruler beginning from the end of the surgery. The visual analogue scale (VAS) is commonly used as the outcome measure for such studies. It is usually presented as a 100-mm horizontal line on which the patient's pain intensity is represented by a point between the extremes of "no pain at all" and "worst pain imaginable." Its simplicity, reliability, and validity, as well as its ratio scale properties, make the VAS the optimal tool for describing pain severity or intensity. |
up to 72 hours after the end of surgery
|
|
time of hospitalization
Time Frame: 4 weeks
|
time of hospitalization in days
|
4 weeks
|
|
number of resected lymph nodes
Time Frame: 4 weeks
|
number of resected lymph nodes
|
4 weeks
|
|
number of resected metastatic nodes
Time Frame: 4 weeks
|
number of resected metastatic nodes
|
4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Marcin Zielinski, MD PhD, Pulmonary Hospital Zakopane
Publications and helpful links
Helpful Links
- Gonzalez D, Paradela M, Garcia J et al. Single-port video-assisted thoracoscopic lobectomy. Interact Cardiovasc Thorac Surg 2011;12:14-5
- Zieliński M, Pankowski J, Hauer L et al: The right upper lobe pulmonary resection performed through the transcervical approach. Eur J Cardiothorac Surg. 2007;32:766-769
- Jakubiak M, Pankowski J, Obrochta A et al. Fast cytological evaluation of lymphatic nodes obtained during transcervical extended mediastinal lymphadenectomy† European Journal of Cardio-Thoracic Surgery 43 (2013) 297-301
- Zieliński M, Nabialek T, Pankowski J. Transcervical uniportal pulmonary lobectomy. JOVS pulmonary transcervical J Vis Surg. 2018;4:42
- 6. Zieliński M. Technical pitfalls of transcervical extended mediastinal lymphadenectomy - how to avoid them and to manage intraooperative complications. Semin Thoracic Surg 2010;22:236-243
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 01/2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-Small Cell Lung Cancer (NSCLC)
-
NCT06881784RecruitingNon-Small Cell Lung Cancer | NSCLC | NSCLC (Non-small Cell Lung Cancer) | NSCLC (Advanced Non-small Cell Lung Cancer) | NSCLC (Non-small Cell Lung Carcinoma)
-
NCT03628144WithdrawnNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | NSCLC Stage IIIB | Non-small Cell Lung Cancer Stage IIIB | NSCLC, Stage IIIA | Non-small Cell Lung Cancer Stage ⅢA
-
NCT05652868TerminatedNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung Cancer
-
NCT07405190Not yet recruitingLung Cancer Non Small Cell | Genomic Alterations | Lung Cancer (Non-Small Cell) | Lung Cancer (NSCLC) | Lung Cancer Non-Small Cell Cancer (NSCLC) | Lung Cancer - Non Small Cell
-
NCT07338396Not yet recruitingNon Small Cell Lung Cancer NSCLC
-
NCT07188480RecruitingNon Small Cell Lung Cancer NSCLC
-
NCT07169708Recruiting
-
NCT07590531Not yet recruitingAdvanced Non-small Cell Lung Cancer (NSCLC)
-
NCT07489066Not yet recruitingCarcinoma | Lung Neoplasms | Non-Small Cell Lung Cancer | Lung Disease | Non-Small-Cell Lung | Carcinoma, Non-Small-Cell Lung (NSCLC) | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamous | Lung Cancer (NSCLC)
-
NCT07150598Not yet recruitingNSCLC Stage IIIB~IV | NSCLC (Advanced Non-small Cell Lung Cancer) | NSCLC Non-small Cell Lung Cancer
Clinical Trials on uniportal lobectomy with complete lymphadenectomy
-
NCT03523468RecruitingLung Cancer | Video-Assisted Thoracic Surgery
-
NCT06577792RecruitingNon Small Cell Lung Cancer
-
NCT06511661Active, not recruitingNon Small Cell Lung Cancer | Residual; State
-
NCT02787187CompletedPancreatic Ductal Adenocarcinoma
-
NCT03961373RecruitingLocally Advanced Gastric Cancer
-
NCT03083951CompletedColorectal Cancer | Sigmoid Cancer
-
NCT01221688Completed
-
NCT04878783Active, not recruitingGastric Cancer | Adenocarcinoma of the Stomach